About Us

Olga Progrebinsky has a Ph.D. degree in Organic Chemistry from Tel-Aviv University and has worked in Teva api’s regulatory affairs group for 13 years and is currently the head of global regulatory affairs at Teva api. The Teva api global RA team is spread across 10 countries and provides regulatory support to all Teva api sites and all Teva api customers worldwide.

Udi Amir is heading API Development, Manufacturing and Supply Operations. Udi is a passionate leader with proven success in driving improvements in operational performance, quality and customer service.

Since joining Teva in 2000, Udi has excelled at a number of leadership roles including Head of Teva api Israel, Site General Manager of our Malanpur site in India, Head of Teva api India Supply Chain & Technical Service, and his most recent role leading Teva api R&D, RA and MS&T.

He holds an Executive MBA from Tel Aviv University, and a Bachelor of Science degree in Chemical Engineering from the Technion Institute”.

Revital Lifshitz has a M.Sc. in organic chemistry from Tel Aviv University, and has been working at Teva api for 21 years. She is currently the senior manager of Teva api Technical and Scientific Support (ScS) for the Japanese, Korean & Chinese markets, and has been in that position for 8 years. Her previous roles in Teva api have included; Customer Service Manager at Teva api International Sales Office, Teva api Contract Development Manager, Chemical R&D Project Manager and R&D Researcher.

Oshrat Frenkel is Associate Director, Pre-Formulation for Teva api Global R&D and holds a Ph.D. in Pharmaceutical Sciences from Hebrew University and an MBA from the Interdisciplinary Center.

Maytal Piran is Director of Physical R&D. She leads the solid state global team of product managers and researchers, specializing in API crystal forms, particle & powder properties. Maytal joined the company in 2008, and has since held multiple roles, including: Director of Teva API Physical R&D, Israel; Manager of Particles & Powder Properties Characterization Group; and Project Manager, Physical R&D.
Maytal has a PhD in Medicine Chemistry from Bar-Ilan University, specializing in solid-state chemistry and nanotechnology.

Arina Ceausu is the Global Analytical R&D Director for teva api, based in Israel. She has been with the organization for 25 years and has an extensive background in API analytical research. Arina has a master’s degree in organic chemical engineering.

Liron Shakoof is Director of Launch Readiness and Planning & Control for the global MS&T unit. Liron has been at Teva since 2010, holding various positions in the Israel manufacturing sites of Teva’s pharma operations, including in the Supply Chain, and Quality and Planning teams.

Liron holds a BSc in Material Engineering from Ben-Gurion University of the Negev and an MBA in Technology Companies Management from the College of Management.

Dr. Augusto Canavesi is Head of New Products Management. He is globally responsible for the development strategy of the new products to be included in Teva api portfolio.
He joined Teva api in 2005 as senior chemist and then took several positions increasing his responsibilities: in 2007 as head of Chemistry in Italy R&D, in 2013 as head of Italy R&D, in 2016 as head of Italy, Mexico and Czech Republic R&D and from 2018 in his current global R&D role.
Dr. Augusto Canavesi received his PhD from the University of Milan in 1996 and after a 2 year experience as a post-doc in Minneapolis at the University of Minnesota, he started his career in the industry as a process chemist. His activity has always been devoted to development of efficient and robust processes for the production of new APIs at industrial scale, mainly related to highly potent APIs (HPAPIs) from anticancer to respiratory drugs.
He is the co-author of 20 research publications and several international patent applications in the area of polymorphism and process chemistry.